Prolactinoma (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Prolactinoma" in English language version.

refsWebsite
Global rank English rank
4th place
4th place
2nd place
2nd place
5th place
5th place
11th place
8th place
1st place
1st place
5,619th place
2,948th place
485th place
440th place

doi.org (Global: 2nd place; English: 2nd place)

  • Glezer A, Bronstein MD (2015). "Prolactinomas". Endocrinol Metab Clin North Am. 44 (1): 71–78. doi:10.1016/j.ecl.2014.11.003. PMID 25732643.
  • Auriemma, Renata S.; Pirchio, Rosa; Pivonello, Claudia; Garifalos, Francesco; Colao, Annamaria; Pivonello, Rosario (2023-08-18). "Approach to the Patient With Prolactinoma". The Journal of Clinical Endocrinology and Metabolism. 108 (9): 2400–2423. doi:10.1210/clinem/dgad174. ISSN 1945-7197. PMC 10438891. PMID 36974474.
  • Ma, Wenbin; Ikeda, Hidetoshi; Yoshimoto, Takashi (2002-07-15). "Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas". Cancer. 95 (2): 258–266. doi:10.1002/cncr.10676. ISSN 0008-543X. PMID 12124824.
  • Fukuhara, Noriaki; Nishiyama, Mitsuru; Iwasaki, Yasumasa (2022-07-24). "Update in Pathogenesis, Diagnosis, and Therapy of Prolactinoma". Cancers. 14 (15): 3604. doi:10.3390/cancers14153604. ISSN 2072-6694. PMC 9331865. PMID 35892862.
  • Mancini T, Casanueva FF, Giustina A (March 2008). "Hyperprolactinemia and prolactinomas". Endocrinology and Metabolism Clinics of North America. 37 (1): 67–99, viii. doi:10.1016/j.ecl.2007.10.013. PMID 18226731.
  • Wildemberg, Luiz Eduardo; Fialho, Christhiane; Gadelha, Monica R. (2021-12-01). "Prolactinomas". La Presse Médicale. Pituitary disorders. 50 (4) 104080. doi:10.1016/j.lpm.2021.104080. ISSN 0755-4982. PMID 34687915.
  • Bankowski BJ, Zacur HA (June 2003). "Dopamine agonist therapy for hyperprolactinemia". Clin Obstet Gynecol. 46 (2): 349–62. doi:10.1097/00003081-200306000-00013. PMID 12808385. S2CID 29368668.
  • Bronstein MD (March 2006). "Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy". Nat Clin Pract Endocrinol Metab. 2 (3): 130–1. doi:10.1038/ncpendmet0135. PMID 16932269. S2CID 10873443.
  • McDowell BD, Wallace RB, Carnahan RM, Chrischilles EA, Lynch CF, Schlechte JA (March 2011). "Demographic differences in incidence for pituitary adenoma". Pituitary. 14 (1): 23–30. doi:10.1007/s11102-010-0253-4. PMC 3652258. PMID 20809113.

lecturio.com (Global: 5,619th place; English: 2,948th place)

  • "Gynecomastia". The Lecturio Medical Concept Library. September 2020. Retrieved 24 July 2021.

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

  • Glezer A, Bronstein MD (2015). "Prolactinomas". Endocrinol Metab Clin North Am. 44 (1): 71–78. doi:10.1016/j.ecl.2014.11.003. PMID 25732643.
  • Yatavelli RK, Bhusal K (2020). "Prolactinoma". StatPearls. PMID 29083585.
  • Auriemma, Renata S.; Pirchio, Rosa; Pivonello, Claudia; Garifalos, Francesco; Colao, Annamaria; Pivonello, Rosario (2023-08-18). "Approach to the Patient With Prolactinoma". The Journal of Clinical Endocrinology and Metabolism. 108 (9): 2400–2423. doi:10.1210/clinem/dgad174. ISSN 1945-7197. PMC 10438891. PMID 36974474.
  • Ma, Wenbin; Ikeda, Hidetoshi; Yoshimoto, Takashi (2002-07-15). "Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas". Cancer. 95 (2): 258–266. doi:10.1002/cncr.10676. ISSN 0008-543X. PMID 12124824.
  • Fukuhara, Noriaki; Nishiyama, Mitsuru; Iwasaki, Yasumasa (2022-07-24). "Update in Pathogenesis, Diagnosis, and Therapy of Prolactinoma". Cancers. 14 (15): 3604. doi:10.3390/cancers14153604. ISSN 2072-6694. PMC 9331865. PMID 35892862.
  • Mancini T, Casanueva FF, Giustina A (March 2008). "Hyperprolactinemia and prolactinomas". Endocrinology and Metabolism Clinics of North America. 37 (1): 67–99, viii. doi:10.1016/j.ecl.2007.10.013. PMID 18226731.
  • Wildemberg, Luiz Eduardo; Fialho, Christhiane; Gadelha, Monica R. (2021-12-01). "Prolactinomas". La Presse Médicale. Pituitary disorders. 50 (4) 104080. doi:10.1016/j.lpm.2021.104080. ISSN 0755-4982. PMID 34687915.
  • Bankowski BJ, Zacur HA (June 2003). "Dopamine agonist therapy for hyperprolactinemia". Clin Obstet Gynecol. 46 (2): 349–62. doi:10.1097/00003081-200306000-00013. PMID 12808385. S2CID 29368668.
  • Bronstein MD (March 2006). "Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy". Nat Clin Pract Endocrinol Metab. 2 (3): 130–1. doi:10.1038/ncpendmet0135. PMID 16932269. S2CID 10873443.
  • McDowell BD, Wallace RB, Carnahan RM, Chrischilles EA, Lynch CF, Schlechte JA (March 2011). "Demographic differences in incidence for pituitary adenoma". Pituitary. 14 (1): 23–30. doi:10.1007/s11102-010-0253-4. PMC 3652258. PMID 20809113.

ncbi.nlm.nih.gov

niddk.nih.gov

  • "Prolactinoma". National Institute Of Diabetes And Digestive And Kidney Diseases. Retrieved 24 July 2021.

oup.com (Global: 485th place; English: 440th place)

academic.oup.com

semanticscholar.org (Global: 11th place; English: 8th place)

api.semanticscholar.org

web.archive.org (Global: 1st place; English: 1st place)

worldcat.org (Global: 5th place; English: 5th place)

search.worldcat.org